Abstract
Trends in cervical cancer in the United States are best expressed by incidence rates. Cancer incidence rates are defined as the annual rate of newly diagnosed cases within a specific population and are usually expressed as the number of cases per 100,000 persons in the population. In general, incidence data are considered the most useful type of descriptive measure because they reflect the probability of the development of a disease within a population and its sub-groups (Lillienfeld 1967). For carcinoma of the cervix in the United States, one can understand trends only through incidence data, since more than 75% of all cases are diagnosed as in situ disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berget A: Screening for Cervical Neoplasia. Dan Med Bull 26: 313, 1979.
Berlie J, Janin ML, Hucer M, Gest J, Brunet M: Mortalité par Cancer du Col d’Utérus en France, de 1950 à 1976. Bull Cancer 66: 395, 1979.
Boyes DA, Nichol TM, Millner AM, Worth AJ: Recent results from the British Columbia Screening program for Cervical Cancer. Am J Obst Gyn 128: 692, 1977.
Christopherson WM: Mass Population Screening for Cervix Cancer. Tumori 62: 297, 1976.
Cutler SJ, Young JL Jr (eds): Third National Cancer Survey; Incidence Data. NCI Monograph 41. Bethesda, MD: US- DHEW, 1975.
Cutler SJ, Young JL Jr: Demographic Patterns of Cancer Incidence. In JF Fraumeni (ed): Persons at High Risk for Cancer. NY: Academic Press Inc., 1975.
Dickinson LE: Control of Cancer of the Uterine Cervix by Cytologic Screening. Gyn One 3: 1, 1975.
Dorn HF: Illness from Cancer in the United States. Reprint No. 2537 from the Public Health Reports. Washington, D.C.: U.S. Gov’t. Printing Office, 1944.
Dorn HF, Cutler SJ: Morbidity from Cancer in the U.S. Public Health Monograph No. 56. Washington, D.C.: U.S. Gov’t. Printing Office, 1959.
Eddy D: ACS Report on the Cancer-Related Health Check-up. CA 30: 215, 1980.
Graham S, Levin ML L, Lillienfeld AM, Sheehe P: Ethnic Derivation as Related to Cancer at Various Sites. Cancer 16: 13, 1963.
Green GH: Cervical Cancer and Cytology Screening in New Zealand. Br J Obst Gyn 85: 881, 1978.
Green GH: Screening and cervical Cancer. Lancet, January 6: 40, 1979.
Hakama M, Rasanen-Virtanen U: Effect of a Mass Screening Program on the Risk of Cervical Cancer. Am J Epi 103: 512, 1976.
Hoover R, Mason TJ, McKay FW, Fraumeni JF Jr: Geographic Patterns of Cancer Mortality in the United States. In JF Fraumeni, Jr (ed): Persons at High Risk of Cancer.NY: Academic Press, Inc., 1975.
Johannesson G, Geirsson G, Day N: The Effect of Mass Screening in Iceland, 1965–74, on the Incidence and Motality of Cervical Carcinoma. Int J Cancer 21: 418, 1978.
Kessler I, Aurelian L: Uterine Cervix. In D Schottenfeld (ed): Cancer Epidemiology and Prevention. Springfield, I11.: C. Thomas, 1975.
Kim K, Rigal RD, Patrick JR, Waltes JK, Bennett A, Nordin, W, Claybrook JR Parekh RR: The Changing Trends of Uterine Cancer and Cytology. Cancer 42: 2439, 1978.
Lillienfeld AM, Pedersen E, Dowd JE: Cancer Epidemiology: Methods of Study. Baltimore: The Johns Hopkins Press, 1967.
Lillienfeld AM, Lillienfeld DE: Foundations of Epidemiology. NY: Oxford U Press, 1980.
Lyon JL, Gardner JW: The Rising Frequency of Hysterectomy; Its Effect on Uterine Cancer Rates. Am J Epi 105: 439, 1977.
MacGregor JE, Teper S: Mortality from Carcinoma of the Cervix Uteri in Britain. Lancet, October 7: 774, 1978.
McLaren HC: Leaves from the Arbor Vitae. Acta Cyt 23: 522, 1979.
Miller AB, Lindsay J, Hill GB: Mortality from Cancer of the Uterus in Canada and Its Relationship to Screening for Cancer of the Cervix. Int J Cancer 17: 602, 1976.
National Center for Health Statistics: Use of Selected Medical Procedures Associated with Preventive Care, U.S. - 1973. DHEW Publication No. (HRA) 77-1538. Rockville, MD.: USDHEW, 1977.
Petrakis NL: Historic Milestones in Cancer Epidemiology. Sem Onc 6: 433, 1979.
Rochat RW: The Prevalence of Cervical Cancer Screening in the United States in 1970. Am J Obstet Gyn 125: 478, 1976.
Stern E, Miscyzynski M, Greenland S, Damus K, Coulson A: ‘Pap’ Testing and Hysterectomy Prevalence: A Survey of Communities with High and Low Cervical Cancer Rates. Am J Epi 106: 296, 1977.
Terris M, Wilson F, Nelson JH Jr: Comparative Epidemiology of Invasive Carcinoma of the Cervix, Carcinoma In Situ, and Cervical Dysplasia. Am J Epi 112: 253, 1980.
Thomas DB: An Epidemiologic Study of Carcinoma In Situ and Squamous Dysplasia of the Uterine Cervix. Am J Epi 98: 10, 1973.
Toit JP du, Van Niekerk WA: Cervical Cytologic Screening Among Females with Nongynecologic Hospital Admission. Obst Gyn 51: 342, 1978.
Walton Report: Cervical Cancer Screening Programs. CMAJ 114: 1003, 1976.
Young JL Jr, Asire AJ, Pollack ES (eds): SEER Program: Cancer Incidence and Mortality in the U.S., 1973–1976. DHEW Publication No. (NIH) 78-1837. Bethesda, MD: USDHEW, 1978.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers
About this chapter
Cite this chapter
Swanson, G.M., Belle, S.H., Young, J.L. (1982). U.S. Trends in Carcinoma of the Cervix: Incidence, Mortality and Survival. In: Hafez, E.S.E., Smith, J.P. (eds) Carcinoma of the Cervix. Developments in Obstetrics and Gynecology, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7485-2_1
Download citation
DOI: https://doi.org/10.1007/978-94-009-7485-2_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7487-6
Online ISBN: 978-94-009-7485-2
eBook Packages: Springer Book Archive